Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis

Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis

Bibliographic Details
Main Authors:	Qin Pan, Han-Qing Chen, Wan-Cheng Chow, Hui-Ping Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Endocrinology
Subjects:	metabolic associated fatty liver disease metabolism steatosis inflammation fibrosis genetics
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1308860/full

Similar Items

Biochemical assessment of metabolic associated fatty liver disease
by: Guerra-Ruiz Armando R., et al.
Published: (2021-03-01)

Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis
by: Itzayana Rodríguez-Antonio, et al.
Published: (2022-03-01)

Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease
by: Chang-Hai Liu, et al.
Published: (2022-06-01)

<b>Analytical methods for evaluation of the fatty acid metabolism in rat liver
by: Eduardo Hideo Gilglioni, et al.
Published: (2018-11-01)

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives
by: Georgiana-Diana Cazac, et al.
Published: (2023-04-01)

Plasma Calprotectin Levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population
by: Arno R. Bourgonje, et al.
Published: (2022-12-01)

Metabolic abnormalities, liver and body fat in American versus Chinese patients with non‐alcoholic fatty liver disease
by: Wei Zhang, et al.
Published: (2022-08-01)

Metabolically associated fatty liver disease – a disease of the 21st century: A review
by: Igor V. Maev, et al.
Published: (2022-07-01)

Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2023-09-01)

Association between remnant cholesterol and insulin resistance levels in patients with metabolic-associated fatty liver disease
by: Shuang Wang, et al.
Published: (2024-02-01)

Serum Uric Acid but Not Ferritin Level Is Associated with Hepatic Fibrosis in Lean Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease: A Community-Based Study
by: Cheng-Han Xie, et al.
Published: (2022-12-01)

Editorial: The broader aspects of non-alcoholic fatty liver disease in children
by: Claudia Mandato, et al.
Published: (2022-10-01)

Clinical Progression of Metabolic-Associated Fatty Liver Disease Is Rare in a Danish Tertiary Liver Center
by: Tea Lund Laursen, et al.
Published: (2022-04-01)

The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
by: Ivana Mikolasevic, et al.
Published: (2022-02-01)

Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease
by: Yuji Xiao, et al.
Published: (2023-10-01)

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
by: Huang J, et al.
Published: (2021-02-01)

The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease
by: Ji-Yeon Seo, et al.
Published: (2021-10-01)

The Prevalence of Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease in Ahvaz, Iran
by: Alireza Jahanshahi, et al.
Published: (2023-12-01)

High prevalence of metabolic diseases, liver steatosis and fibrosis among Chinese psychiatric patients
by: Huixia Li, et al.
Published: (2023-03-01)

Iron metabolism and metabolic dysfunction-associated fatty liver disease
by: Élthes Zoltán-Zsombor, et al.
Published: (2023-09-01)

Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome
by: Ying-Hsiu Lin, et al.
Published: (2018-11-01)

Atherogenic Index of Plasma in Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2022-08-01)

Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease
by: Kun-Lin Cheng, et al.
Published: (2024-01-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
by: Hirsh D. Trivedi, et al.
Published: (2021-09-01)

The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction
by: Su-bin Lee, et al.
Published: (2024-03-01)

The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease
by: Jie He, et al.
Published: (2022-08-01)

Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms
by: James Westley Heinle, et al.
Published: (2023-05-01)

The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations
by: Ziyan Feng, et al.
Published: (2024-03-01)

Predictors of hepatic steatosis in living liver donors
by: M. G. Minina, et al.
Published: (2022-12-01)

Non-alcoholic fatty liver disease and metabolic liver dysfunction in the new coronavirus infection COVID-19
by: A. A. Karaseva, et al.
Published: (2021-12-01)

Phospholipids in non-alcoholic fatty liver disease
by: V. V. Skvortsov, et al.
Published: (2022-04-01)

Hyperferritinemia Correlates to Metabolic Dysregulation and Steatosis in Chinese Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients
by: Wang Q, et al.
Published: (2022-05-01)

Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction
by: Rabina Mainali, et al.
Published: (2021-02-01)

Performance Evaluation of a Novel Non-Invasive Test for the Detection of Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
by: Anna Stefanska, et al.
Published: (2024-01-01)

Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII
by: Eyun Song, et al.
Published: (2021-05-01)

Fibrosis Predictive Score in Caucasian Patients with Metabolic Syndrome
by: Mare R, et al.
Published: (2022-06-01)

Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B—A Retrospective Cohort Study
by: Wang QX, et al.
Published: (2022-08-01)

Non-alcoholic fatty liver disease: features of metabolic changes at different stages of the disease
by: Yu.M. Stepanov, et al.
Published: (2018-02-01)

Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by: Avneet Singh, et al.
Published: (2024-02-01)